Accumetrics, Inc. Release: Platelet Reactivity Considerations Center Stage at American College of Cardiology.12

CHICAGO--(BUSINESS WIRE)--Accumetrics Inc., developer of the VerifyNow® System, the first rapid and easy-to-use point-of-care system for measuring platelet reactivity to multiple antiplatelet agents, today announced that platelet reactivity testing and antiplatelet therapy choices remain at the forefront of the Annual Scientific Session of the American College of Cardiology. Over 150 sessions and posters covered antiplatelet therapy and platelet reactivity testing, including the use of newer P2Y12 inhibitors in patients with high on-clopidogrel platelet reactivity, the potential utilization of various antiplatelet dosing strategies in low weight patients, pre-surgical use of platelet reactivity testing, and the potential impact of the imminent release of generic clopidogrel to the US market in May, 2012.